Shareholder alert: pomerantz law firm investigates claims on behalf of investors of regeneron pharmaceuticals, inc. - regn

New york , july 2, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
REGN Ratings Summary
REGN Quant Ranking